doi.org/10.1182/blood-2017-01-761973, hdl.handle.net/1765/100107
Blood
Erasmus MC: University Medical Center Rotterdam

Fischer, K., Al-Sawaf, O. (Othman), Fink, A.-M. (Anna-Maria), Dixon, M. (Mark), Bahlo, J. (Jasmin), Warburton, S. (Simon), Kipps, T.J. (Thomas J.), Weinkove, R. (Robert), Robinson, S. (Sue), Seiler, T. (Till), Opat, S., Owen, C., López, J. (Javier), Humphrey, K., Humerickhouse, R., Tausch, E. (Eugen), Frenzel, L. (Lukas), Eichhorst, B., Wendtner, C. M., … Hallek, M. (2017). To the editor: Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood, 129(19), 2702–2705.https://doi.org/10.1182/blood-2017-01-761973